new IV anticoagulant, Angiomax (bivalirudin)

You'll see a new IV anticoagulant, Angiomax (bivalirudin).

It will be used as an alternative to heparin for patients undergoing angioplasty. It seems to be safer and more effective.

Patients who get Angiomax have a lower risk of serious bleeding and fewer ischemic complications...heart attack, death, or repeat revascularization procedures.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote